INNATE PHARMA S A's ticker is IPHA and the CUSIP is 45781K204. A total of 5 filers reported holding INNATE PHARMA S A in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,265 | -17.8% | 500 | 0.0% | 0.00% | – |
| Q2 2023 | $1,538 | +7.9% | 500 | 0.0% | 0.00% | – |
| Q1 2023 | $1,425 | -23.6% | 500 | 0.0% | 0.00% | – |
| Q4 2022 | $1,865 | +86.5% | 500 | 0.0% | 0.00% | – |
| Q3 2022 | $1,000 | 0.0% | 500 | 0.0% | 0.00% | – |
| Q2 2022 | $1,000 | -50.0% | 500 | 0.0% | 0.00% | – |
| Q1 2022 | $2,000 | 0.0% | 500 | 0.0% | 0.00% | – |
| Q4 2021 | $2,000 | -33.3% | 500 | 0.0% | 0.00% | – |
| Q3 2021 | $3,000 | +50.0% | 500 | -23.1% | 0.00% | – |
| Q2 2021 | $2,000 | -100.0% | 650 | -50.0% | 0.00% | – |
| Q1 2021 | $5,604,000 | +140000.0% | 1,300 | +18.2% | 0.00% | – |
| Q4 2020 | $4,000 | 0.0% | 1,100 | 0.0% | 0.00% | – |
| Q3 2020 | $4,000 | -50.0% | 1,100 | 0.0% | 0.00% | – |
| Q2 2020 | $8,000 | +14.3% | 1,100 | 0.0% | 0.00% | – |
| Q1 2020 | $7,000 | 0.0% | 1,100 | 0.0% | 0.00% | – |
| Q4 2019 | $7,000 | – | 1,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BANK OF AMERICA CORP /DE/ | 46,749 | $133,235 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 61,899 | $176 | 0.00% |
| MORGAN STANLEY | 48,722 | $138,858 | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 13,315 | $37,815 | 0.00% |
| Steward Partners Investment Advisory, LLC | 500 | $1,425 | 0.00% |
| Optiver Holding B.V. | 224,097 | $636,435 | 0.00% |
| BARCLAYS PLC | 412 | $1 | 0.00% |
| ROYAL BANK OF CANADA | 124 | $0 | 0.00% |
| UBS Group AG | 1,259 | $3,588 | 0.00% |